Cargando…

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy

Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41–43 °C), yielding heterogeneities in the perito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Löke, Daan R., Helderman, Roxan F. C. P. A., Franken, Nicolaas A. P., Oei, Arlene L., Tanis, Pieter J., Crezee, Johannes, Kok, H. Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808385/ https://www.ncbi.nlm.nih.gov/pubmed/33427507 http://dx.doi.org/10.1080/10717544.2020.1862364

Ejemplares similares

Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2019)

Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
por: Löke, Daan R., et al.
Publicado: (2023)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
por: Löke, Daan R., et al.
Publicado: (2020)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
por: Helderman, Roxan F.C.P.A., et al.
Publicado: (2020)

Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2023)

Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2022)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2021)

Hyperthermia-Based Anti-Cancer Treatments
por: Crezee, Johannes, et al.
Publicado: (2021)

Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Johannes, et al.
Publicado: (2020)

The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Hans, et al.
Publicado: (2019)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy
por: Gupta, Nishkarsh, et al.
Publicado: (2019)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
por: Van Hattum, J. W., et al.
Publicado: (2022)

Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative
por: Leiting, Jennifer L, et al.
Publicado: (2020)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014)

Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018)

Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
por: Kim, Woo Ram, et al.
Publicado: (2017)

Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
por: Ceelen, Wim, et al.
Publicado: (2021)

Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
por: Oei, Arlene L., et al.
Publicado: (2015)

Assessment of Hyperthermic Intraperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells()
por: Ji, Zhonghe, et al.
Publicado: (2016)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?
por: Helm, C. William
Publicado: (2015)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?
por: Spiliotis, John
Publicado: (2020)

Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
por: Kim, S.I., et al.
Publicado: (2021)

Reflex Anuria: A Complication of Hyperthermic Intraperitoneal Chemotherapy
por: Fayed, Mohamed, et al.
Publicado: (2021)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion
por: Liesenfeld, Lukas F., et al.
Publicado: (2023)

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)

Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Huffman, Olivia G., et al.
Publicado: (2023)

Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
por: IJff, Marloes, et al.
Publicado: (2018)

Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
por: Elming, Pernille B., et al.
Publicado: (2019)

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017)

Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
por: Jiao, Jie, et al.
Publicado: (2020)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
por: Leigh, Natasha, et al.
Publicado: (2020)

Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Alshammari, Turki, et al.
Publicado: (2019)

Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ryu, Jung-Hee, et al.
Publicado: (2021)

Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer
por: Zeng, Lisi, et al.
Publicado: (2022)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j309j1d6l43hpur5hio7tdhio9